Legend Biotech

(NASDAQ) LEGN

Current Price$25.24

Market Cap$4.36B

Since IPO (2020)-36%

5 Year-22%

1 Year-31%

1 Month+24%

Legend Biotech Financials at a Glance

Market Cap

$4.36B

Revenue (TTM)

$1.03B

Net Income (TTM)

$297.02M

EPS (TTM)

$-1.62

P/E Ratio

-14.60

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$25.24

Volume

57,039

Open

$23.61

Price

$25.24

Volume

57,039

Open

$23.61

Previous Close

$23.59

Daily Range

$23.61 - $25.41

52-Week Range

$16.24 - $45.30

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$25.24

Volume

57,039

Open

$23.61

Previous Close

$23.59

Daily Range

$23.61 - $25.41

52-Week Range

$16.24 - $45.30

LEGN News

Person in a lab gazing into a microscope

Page 1

LEGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Legend Biotech

Industry

Biotechnology

Sector

Health Care

Employees

2,900

CEO

Ying Huang, PhD

Website

www.legendbiotech.com

Headquarters

Somerset, NJ 08873, US

LEGN Financials

Key Financial Metrics (TTM)

Gross Margin

60%

Operating Margin

-13%

Net Income Margin

-29%

Return on Equity

-29%

Return on Capital

-12%

Return on Assets

-17%

Earnings Yield

-6.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.36B

Shares Outstanding

184.94M

Volume

57.04K

Avg. Volume

2.00M

Financials (TTM)

Gross Profit

$622.44M

Operating Income

$136.86M

EBITDA

$107.78M

Operating Cash Flow

$100.47M

Capital Expenditure

$67.58M

Free Cash Flow

$168.04M

Cash & ST Invst.

$948.60M

Total Debt

$413.70M

Legend Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$307.64M

+64.9%

Gross Profit

$183.60M

+63.1%

Gross Margin

59.68%

N/A

Market Cap

$4.36B

N/A

Market Cap/Employee

$1.68M

N/A

Employees

2,600

N/A

Net Income

$31.03M

-218.1%

EBITDA

$7.73M

-114.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$534.90M

-30.7%

Accounts Receivable

$250.30M

+100.4%

Inventory

$32.00M

+33.9%

Long Term Debt

$87.20M

-74.8%

Short Term Debt

$326.50M

+6710.6%

Return on Assets

-17.13%

N/A

Return on Invested Capital

-12.37%

N/A

Free Cash Flow

$126.56M

-49.9%

Operating Cash Flow

$105.64M

-28.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XENEXenon Pharmaceuticals Inc.

XENEXenon Pharmaceuticals Inc.$57.70+2.79%

SRRKScholar Rock Holding Corporation

SRRKScholar Rock Holding Corporation$46.84+1.00%

CGONCG Oncology, Inc. Common stock

CGONCG Oncology, Inc. Common stock$67.48+1.83%

TARSTarsus Pharmaceuticals, Inc.

TARSTarsus Pharmaceuticals, Inc.$63.64+0.03%

IRONDisc Medicine, Inc.

IRONDisc Medicine, Inc.$67.41+0.74%

IDYAIDEAYA Biosciences, Inc.

IDYAIDEAYA Biosciences, Inc.$28.84+2.32%

ZLABZai Lab Limited

ZLABZai Lab Limited$21.29-1.16%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.10-0.02%

INTCIntel

INTCIntel$96.48-0.03%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.02+2.47%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+1.07%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.75+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.83+0.01%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.12-0.09%

Questions About LEGN

What is the current price of Legend Biotech?

Legend Biotech is trading at $25.17 per share.

What is the 52-week range for Legend Biotech?

Over the past 52 weeks, Legend Biotech has traded between $16.24 and $45.30.

How much debt does Legend Biotech have?

As of the most recent reporting period, Legend Biotech reported total debt of $413.70M.

How much cash does Legend Biotech have on hand?

Legend Biotech reported $901.90M in cash and cash equivalents in its most recent financial results.

What is Legend Biotech’s dividend yield?

Legend Biotech does not currently have a dividend yield.

Legend Biotech

Legend Biotech Financials at a Glance

LEGN News

Why Legend Biotech Stock Crushed the Market on Monday

What Companies Does Johnson & Johnson Own?

After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?

Why Shares of Legend Biotech Jumped Wednesday

Why Legend Biotech's Shares Jumped 14.2% On Tuesday

Why Legend Biotech's Shares Jumped 11.8% on Wednesday

2 Biotechs With Recent FDA Approvals to Hold for the Next Decade

Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.

LEGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Legend Biotech

LEGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Legend Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LEGN

What is the current price of Legend Biotech?

What is the 52-week range for Legend Biotech?

How much debt does Legend Biotech have?

How much cash does Legend Biotech have on hand?

What is Legend Biotech’s dividend yield?

Premium Investing Services